CERS2 and fatty liver disease: A study found that hepatocyte-specific knockdown of CERS2 inhibited the p38 MAPK and ERK1/ERK2 signaling pathways in mouse liver, thereby protecting mice from high-fat diet-induced hepatic steatosis and IR [40].